Most patients with chronic heart failure have detectable troponin concentrations when evaluated by high-sensitivity assays. The prognostic relevance of this finding has not been clearly established so far. We aimed to assess high-sensitivity troponin assay for risk stratification in chronic heart failure through a meta-analysis approach
BACKGROUND: Cardiac troponins are emerging as important prognostic markers in chronic cardiovascula...
Background: High-sensitivity (hs) assays allow to measure cardiac troponin T and I (cTnT/I) even in ...
Background: High-sensitivity (hs) assays allow to measure cardiac troponin T and I (cTnT/I) even in ...
Most patients with chronic heart failure have detectable troponin concentrations when evaluated by h...
Most patients with chronic heart failure have detectable troponin concentrations when evaluated by h...
Most patients with chronic heart failure have detectable troponin concentrations when evaluated by h...
Most patients with chronic heart failure have detectable troponin concentrations when evaluated by h...
BACKGROUND: Most patients with chronic heart failure have detectable troponin concentrations when ev...
BACKGROUND: Most patients with chronic heart failure have detectable troponin concentrations when ev...
BACKGROUND: Most patients with chronic heart failure have detectable troponin concentrations when ev...
BACKGROUND: Most patients with chronic heart failure have detectable troponin concentrations when ev...
BACKGROUND: Most patients with chronic heart failure have detectable troponin concentrations when ev...
BACKGROUND: Most patients with chronic heart failure have detectable troponin concentrations when ev...
BACKGROUND: Most patients with chronic heart failure have detectable troponin concentrations when ev...
BACKGROUND: Most patients with chronic heart failure have detectable troponin concentrations when ev...
BACKGROUND: Cardiac troponins are emerging as important prognostic markers in chronic cardiovascula...
Background: High-sensitivity (hs) assays allow to measure cardiac troponin T and I (cTnT/I) even in ...
Background: High-sensitivity (hs) assays allow to measure cardiac troponin T and I (cTnT/I) even in ...
Most patients with chronic heart failure have detectable troponin concentrations when evaluated by h...
Most patients with chronic heart failure have detectable troponin concentrations when evaluated by h...
Most patients with chronic heart failure have detectable troponin concentrations when evaluated by h...
Most patients with chronic heart failure have detectable troponin concentrations when evaluated by h...
BACKGROUND: Most patients with chronic heart failure have detectable troponin concentrations when ev...
BACKGROUND: Most patients with chronic heart failure have detectable troponin concentrations when ev...
BACKGROUND: Most patients with chronic heart failure have detectable troponin concentrations when ev...
BACKGROUND: Most patients with chronic heart failure have detectable troponin concentrations when ev...
BACKGROUND: Most patients with chronic heart failure have detectable troponin concentrations when ev...
BACKGROUND: Most patients with chronic heart failure have detectable troponin concentrations when ev...
BACKGROUND: Most patients with chronic heart failure have detectable troponin concentrations when ev...
BACKGROUND: Most patients with chronic heart failure have detectable troponin concentrations when ev...
BACKGROUND: Cardiac troponins are emerging as important prognostic markers in chronic cardiovascula...
Background: High-sensitivity (hs) assays allow to measure cardiac troponin T and I (cTnT/I) even in ...
Background: High-sensitivity (hs) assays allow to measure cardiac troponin T and I (cTnT/I) even in ...